Link Details
| ID: | 1846 |
| Title: | Pharmion And MethylGene Announce U.S. Orphan Drug Designation Granted For MGCD0103 For The Treatment - http://www.medicalnewstoday.com/articles/80280.php |
| Pagerank: | N/A |
| Description: | Pharmion Corporation (Nasdaq: PHRM), along with its collaborator MethylGene Inc. (TSX: MYG), today announced that the U.S. Food and Drug Administration (FDA) has designated the Companies histone deacetylase (HDAC) inhibitor, MGCD0103, as an Orphan Drug for the treatment of Hodgkins lymphoma in the United States. [click link for full article] |
| Category: | |
| Link Owner: | |
| Date Added: | August 22, 2007 07:00:00 AM |
| Number Hits: | 0 |